arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

agilon health, inc.

AGL
$113.94 ▲ +17.76 (+18.47%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
7 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

agilon health, inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield —
Revenue Growth -2.1% ↘
Op. Margin -7.8% ↘
ROIC -1328.1% ↘
FCF / Share $-7.19 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.93B
↓ -2.1% —
Net Income Profit after all expenses
$-391.35M
↓ -50.4% —
Operating Margin Operating profit as % of sales
-7.8%
↓ -62.0% 17th
FCF / Share Free cash flow per share
$-7.19
↓ -66.3% —
Long-Term Debt Long-term obligations
$34.99M
— +0.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
19
Financial Health ↓
14
Cash Quality ↓
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 26 quarters